Results 91 to 100 of about 1,677,629 (133)

Evolving Concepts in the Diagnosis and Management of Fibromyalgia: A Moving Target. [PDF]

J Pain Res
Doan HN, Moon JS, Park WT, Baek J, Chang MC.   +4 more
europepmc   +1 more source

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. [PDF]

BMC Neurol
Li J, Zhou R, Deng J, Zhou H, Hu J, Wang X.   +5 more
europepmc   +1 more source

Pharmacologic treatment of fibromyalgia: an update. [PDF]

Front Pharmacol
Li Y, Li Y, Wu S, Long M, Chen X, Wang Y, Zhao J, Zhao J, He B, Chang C, Jiao J.   +10 more
europepmc   +1 more source

Response to Letter to the Editor Regarding "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary". [PDF]

Neurol Ther
Ruoff C, Candler S, Black J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Pharmacokinetics of Once-Nightly Sodium Oxybate FT218: Food Effect and Relative Biovailability Compared to Twice-Nightly Sodium Oxybate (629)

Neurology, 2020
David Seiden, Jordan Dubow
exaly   +2 more sources

The Pharmacokinetic-Adverse Event Relationship For FT218, a Once-Nightly Sodium Oxybate Formulation (1168)

Neurology, 2020
David Seiden, Jordan Dubow
exaly   +2 more sources

0589 Dose Titration of Once-Nightly Sodium Oxybate: Analysis of Interim Data From RESTORE

SLEEP, 2023
Abstract Introduction FT218 (LUMRYZ™) is an investigational once-nightly sodium oxybate (ON-SXB) for treatment of adults with narcolepsy type 1 (NT1) or type 2 (NT2). The efficacy and safety of ON-SXB at doses 6, 7.5, and 9 g in patients with NT1/NT2 were confirmed in the phase 3 REST-ON clinical ...
Asim Roy, Brian Abaluck, Thomas Stern, Clete Kushida, Jordan Dubow, Jennifer Gudeman   +5 more
openaire   +1 more source

Pharmacokinetics and Dose Proportionality of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy (501)

Neurology, 2020
David Seiden, Jordan Dubow
exaly   +2 more sources

Pharmacokinetics and Formulation Selection of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy (495)

Neurology, 2020
David Seiden, Jordan Dubow
exaly   +2 more sources

0573 Application of AASM Clinical Significance Thresholds to Once-Nightly Sodium Oxybate for Improvement in Narcolepsy Symptoms

SLEEP, 2023
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; FT218), an investigational, extended-release treatment, was evaluated for the treatment of narcolepsy in adults in the phase 3 REST-ON clinical trial (NCT02720744).
Thomas Roth, Michael Thorpy, Clete Kushida, Anne Morse, Jordan Dubow, Jennifer Gudeman, Yves Dauvilliers   +6 more
openaire   +1 more source